Cellfx
Payments companies reported to CMS as associated with Cellfx. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Cellfx, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Cellfx
These are the largest totals companies reported as associated with Cellfx. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Niv Ad | Takoma Park, MD | $605,988.96 | |
| David Kenigsberg | Fort Lauderdale, FL | Clinical Cardiac Electrophysiology | $482,552.28 |
| Gansevoort Dunnington | Richmond, VA | Interventional Cardiology | $440,131.71 |
| Ralph Tufano | Sarasota, FL | Otolaryngology | $364,935.65 |
| Jacob Koruth | New York, NY | Clinical Cardiac Electrophysiology | $207,189.03 |
| Emad Kandil | Owings Mills, MD | Surgery | $189,406.73 |
| Gansevoort Dunnington | Saint Helena, CA | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $137,102.67 |
| Alireza Falahati-Nini | Salt Lake City, UT | Endocrinology, Diabetes & Metabolism | $130,225.15 |
| Richard Harding | Phoenix, AZ | Surgery | $118,514.33 |
| Thomas Fahey | New York, NY | Surgery | $84,873.75 |
Prescribed Cellfx?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.